Atopic dermatitis management in adults and older children rarely translates cleanly to infants and toddlers — a gap that carries real consequences when the disease is most active and the developing body is most vulnerable. Understanding why early childhood represents a physiologically distinct clinical challenge matters for every parent, pediatrician, and dermatologist navigating this increasingly prevalent condition.
This clinical review in Immunology and Allergy Clinics of North America outlines the unique disease dynamics of atopic dermatitis when it manifests during the earliest years of life, when the condition most commonly originates. Key concerns include heightened transepidermal drug absorption due to immature skin barrier function, elevated susceptibility to secondary bacterial and viral infections, greater severity of xerosis, and the complicating factor of teething-associated facial skin eruptions that can mimic or exacerbate eczematous flares. The review addresses the safety profiles of systemic immunomodulatory agents in pediatric cohorts, the potential impact of chronic inflammation on growth trajectories and tactile sensory development, and the interplay between atopic dermatitis and vaccine immunogenicity. Caregiver-centered treatment planning is framed not as a soft consideration but as a clinical necessity tied to adherence and outcomes.
This review is clinically oriented rather than data-driven — it synthesizes existing knowledge rather than presenting new trial results, which limits its evidentiary weight. Nevertheless, it addresses a genuine deficiency in how atopic dermatitis guidelines are applied in practice: pediatric dosing and safety data for newer biologics and JAK inhibitors remain thin for the under-two age group, and most randomized trials have skewed toward older children. The overarching framework — preventing long-term atopic march comorbidities such as asthma and food allergy by optimizing early skin barrier management — reflects the current scientific consensus and is well-supported by mechanistic research. Incremental as a standalone piece, this review is practically valuable as a structured clinical reference for practitioners managing high-risk pediatric populations.